IGC Pharma Inc (IGC)
0.5112
-0.01
(-1.69%)
USD |
NYAM |
May 03, 16:00
0.4955
-0.02
(-3.07%)
Pre-Market: 20:00
IGC Pharma Revenue (Annual): 0.911M for March 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| March 31, 2023 | 0.911M |
| March 31, 2022 | 0.397M |
| March 31, 2021 | 0.898M |
| March 31, 2020 | 4.072M |
| March 31, 2019 | 5.116M |
| March 31, 2018 | 2.193M |
| March 31, 2017 | 0.5804M |
| March 31, 2016 | 6.367M |
| Date | Value |
|---|---|
| March 31, 2015 | 7.680M |
| March 31, 2014 | 2.273M |
| March 31, 2013 | 8.03M |
| March 31, 2012 | 4.200M |
| March 31, 2011 | 4.074M |
| March 31, 2010 | 17.90M |
| March 31, 2009 | 35.34M |
| March 31, 2008 | 2.188M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.397M
Minimum
2022
4.072M
Maximum
2020
1.570M
Average
0.9045M
Median
Revenue (Annual) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.202M |
| NovaBay Pharmaceuticals Inc | 14.73M |
| Protalix BioTherapeutics Inc | 65.49M |
| Palatin Technologies Inc | 4.854M |